OBJECTIVE: Susceptibility to inflammatory arthritis is determined by a complex set of environmental and genetic factors, but only a portion of the genetic effect can be explained. Conventional genome-wide screens of arthritis models using crosses between inbred mice have been hampered by the low resolution of results and by the restricted range of natural genetic variation sampled. The aim of this study was to address these limitations by performing a genome-wide screen for determinants of arthritis severity using a genetically heterogeneous cohort of mice. METHODS: Heterogeneous stock (HS) mice derive from 8 founder inbred strains by serial intercrossing (n>60), resulting in fine-grained genetic variation. With a cohort of 570 HS mice, we performed a genome-wide screen for determinants of arthritis severity in the K/BxN serum-transfer model. RESULTS: We mapped regions on chromosomes 1, 2, 4, 6, 7, and 15 that contain quantitative trait loci influencing arthritis severity at a resolution of a few megabases. In several instances, these regions proved to contain 2 quantitative trait loci: the region on chromosome 2 included the C5 fraction of complement known to be required for K/BxN serum-transfer arthritis but also contained a second adjacent quantitative trait locus, for which an intriguing candidate is Ptgs1 (Cox1). Interesting candidates on chromosome 4 included the Padi family, encoding the peptidyl arginine deiminases responsible for citrulline protein modification; suggestively, Padi2 and Padi4 RNA expression was correlated with arthritis severity in HS mice. CONCLUSION: These results provide a broad overview of the genetic variation that controls the severity of K/BxN serum-transfer arthritis and suggest intriguing candidate genes for further study.
OBJECTIVE: Susceptibility to inflammatory arthritis is determined by a complex set of environmental and genetic factors, but only a portion of the genetic effect can be explained. Conventional genome-wide screens of arthritis models using crosses between inbred mice have been hampered by the low resolution of results and by the restricted range of natural genetic variation sampled. The aim of this study was to address these limitations by performing a genome-wide screen for determinants of arthritis severity using a genetically heterogeneous cohort of mice. METHODS: Heterogeneous stock (HS) mice derive from 8 founder inbred strains by serial intercrossing (n>60), resulting in fine-grained genetic variation. With a cohort of 570 HS mice, we performed a genome-wide screen for determinants of arthritis severity in the K/BxN serum-transfer model. RESULTS: We mapped regions on chromosomes 1, 2, 4, 6, 7, and 15 that contain quantitative trait loci influencing arthritis severity at a resolution of a few megabases. In several instances, these regions proved to contain 2 quantitative trait loci: the region on chromosome 2 included the C5 fraction of complement known to be required for K/BxN serum-transfer arthritis but also contained a second adjacent quantitative trait locus, for which an intriguing candidate is Ptgs1 (Cox1). Interesting candidates on chromosome 4 included the Padi family, encoding the peptidyl arginine deiminases responsible for citrulline protein modification; suggestively, Padi2 and Padi4 RNA expression was correlated with arthritis severity in HS mice. CONCLUSION: These results provide a broad overview of the genetic variation that controls the severity of K/BxN serum-transfer arthritis and suggest intriguing candidate genes for further study.
Authors: Eli A Stahl; Soumya Raychaudhuri; Elaine F Remmers; Gang Xie; Stephen Eyre; Brian P Thomson; Yonghong Li; Fina A S Kurreeman; Alexandra Zhernakova; Anne Hinks; Candace Guiducci; Robert Chen; Lars Alfredsson; Christopher I Amos; Kristin G Ardlie; Anne Barton; John Bowes; Elisabeth Brouwer; Noel P Burtt; Joseph J Catanese; Jonathan Coblyn; Marieke J H Coenen; Karen H Costenbader; Lindsey A Criswell; J Bart A Crusius; Jing Cui; Paul I W de Bakker; Philip L De Jager; Bo Ding; Paul Emery; Edward Flynn; Pille Harrison; Lynne J Hocking; Tom W J Huizinga; Daniel L Kastner; Xiayi Ke; Annette T Lee; Xiangdong Liu; Paul Martin; Ann W Morgan; Leonid Padyukov; Marcel D Posthumus; Timothy R D J Radstake; David M Reid; Mark Seielstad; Michael F Seldin; Nancy A Shadick; Sophia Steer; Paul P Tak; Wendy Thomson; Annette H M van der Helm-van Mil; Irene E van der Horst-Bruinsma; C Ellen van der Schoot; Piet L C M van Riel; Michael E Weinblatt; Anthony G Wilson; Gert Jan Wolbink; B Paul Wordsworth; Cisca Wijmenga; Elizabeth W Karlson; Rene E M Toes; Niek de Vries; Ann B Begovich; Jane Worthington; Katherine A Siminovitch; Peter K Gregersen; Lars Klareskog; Robert M Plenge Journal: Nat Genet Date: 2010-05-09 Impact factor: 38.330
Authors: Koichiro Ohmura; Alyssa Johnsen; Adriana Ortiz-Lopez; Paul Desany; Matt Roy; Whitney Besse; John Rogus; Molly Bogue; Anne Puech; Mark Lathrop; Diane Mathis; Christophe Benoist Journal: Proc Natl Acad Sci U S A Date: 2005-08-19 Impact factor: 11.205
Authors: William Valdar; Leah C Solberg; Dominique Gauguier; Stephanie Burnett; Paul Klenerman; William O Cookson; Martin S Taylor; J Nicholas P Rawlins; Richard Mott; Jonathan Flint Journal: Nat Genet Date: 2006-07-09 Impact factor: 38.330
Authors: Mei Chen; Eric Boilard; Peter A Nigrovic; Patsy Clark; Daigen Xu; Garret A Fitzgerald; Laurent P Audoly; David M Lee Journal: Arthritis Rheum Date: 2008-05
Authors: Yanming Wang; Ming Li; Sonja Stadler; Sarah Correll; Pingxin Li; Danchen Wang; Ryo Hayama; Lauriebeth Leonelli; Hyunsil Han; Sergei A Grigoryev; C David Allis; Scott A Coonrod Journal: J Cell Biol Date: 2009-01-19 Impact factor: 10.539
Authors: Timea Besenyei; Andras Kadar; Beata Tryniszewska; Julia Kurko; Tibor A Rauch; Tibor T Glant; Katalin Mikecz; Zoltan Szekanecz Journal: Clin Dev Immunol Date: 2012-12-06
Authors: Girish Srinivas; Steffen Möller; Jun Wang; Sven Künzel; Detlef Zillikens; John F Baines; Saleh M Ibrahim Journal: Nat Commun Date: 2013 Impact factor: 14.919
Authors: J Phillippi; Y Xie; D R Miller; T A Bell; Z Zhang; A B Lenarcic; D L Aylor; S H Krovi; D W Threadgill; F Pardo-Manuel de Villena; W Wang; W Valdar; J A Frelinger Journal: Genes Immun Date: 2013-11-07 Impact factor: 2.676